Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Summit Therapeutics (SMMT) Amortizatization of Intangibles (2019 - 2025)

Summit Therapeutics (SMMT) has disclosed Amortizatization of Intangibles for 7 consecutive years, with $3.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Amortizatization of Intangibles rose 228.38% year-over-year to $3.0 million, compared with a TTM value of $7.0 million through Dec 2025, up 171.97%, and an annual FY2025 reading of $7.0 million, up 171.97% over the prior year.
  • Amortizatization of Intangibles was $3.0 million for Q4 2025 at Summit Therapeutics, up from $1.0 million in the prior quarter.
  • Across five years, Amortizatization of Intangibles topped out at $3.0 million in Q4 2025 and bottomed at -$2.4 million in Q4 2024.
  • Average Amortizatization of Intangibles over 5 years is $864705.9, with a median of $310000.0 recorded in 2022.
  • The sharpest move saw Amortizatization of Intangibles soared 835.81% in 2023, then plummeted 1229.81% in 2024.
  • Year by year, Amortizatization of Intangibles stood at $252000.0 in 2021, then fell by 13.89% to $217000.0 in 2022, then dropped by 4.15% to $208000.0 in 2023, then tumbled by 1229.81% to -$2.4 million in 2024, then soared by 228.38% to $3.0 million in 2025.
  • Business Quant data shows Amortizatization of Intangibles for SMMT at $3.0 million in Q4 2025, $1.0 million in Q2 2025, and $3.0 million in Q1 2025.